Silo Pharma Reports Third Quarter Results and Operating Highlights Post published:November 11, 2021 Post category:Press Release
Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’ Veterans & Families Forum on November 10, 2021 Post published:November 10, 2021 Post category:Press Release
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials Post published:November 10, 2021 Post category:Press Release
Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study Post published:November 10, 2021 Post category:Press Release
Nova Mentis Files Genetic Neuroinflammatory Disease Patent Post published:November 9, 2021 Post category:Press Release
MYND Executes LOI to Enter into a Clinical Research Collaboration with Revitalist Post published:November 9, 2021 Post category:Press Release
COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021 Post published:November 9, 2021 Post category:Press Release
COMPASS Pathways Shares Positive Topline Results from Phase 2b COMP360 Study Post published:November 9, 2021 Post category:Press Release
Mindset Pharma Announces Poster Presentation of Preclinical Data for Benchmarking Next-Generation Psychedelics at Neuroscience 2021 Post published:November 8, 2021 Post category:Press Release
Cybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental Health Post published:November 8, 2021 Post category:Press Release